JNJ: Johnson & Johnson Stocks News on July 1, 2025

Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever

JNJ

Motley Fool

5 days ago

Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever

Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements

JNJ

GlobeNewswire

5 days ago

Retinitis Pigmentosa Research Report 2025: $25+ Bn Market Opportunities and Strategies to 2034 - Gene Therapy Poised as Fastest Growing Treatment Segment, Strategic Collaborations Drive Advancements

Johnson & Johnson CAR T Therapy Shows 80% Response in Lymphoma Trial

JNJ

Insider Monkey

5 days ago

Johnson & Johnson CAR T Therapy Shows 80% Response in Lymphoma Trial

Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US

JNJ

Insider Monkey

6 days ago

Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US

Johnson & Johnson MedTech Expands VOLT Platform With New Wrist, Upper Arm Fracture Systems

JNJ

Insider Monkey

6 days ago

Johnson & Johnson MedTech Expands VOLT Platform With New Wrist, Upper Arm Fracture Systems

J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD

JNJ

Insider Monkey

6 days ago

J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD

Johnson & Johnson announces new data presented at EAN of IMAAVY

JNJ

TipRanks

6 days ago

Johnson & Johnson announces new data presented at EAN of IMAAVY

MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal

JNJ

Zacks

6 days ago

MRK's Winrevair Phase III Study in Newly Diagnosed PAH Meets Goal

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

JNJ

Zacks

7 days ago

Pfizer to Face Several Headwinds: Can It Successfully Navigate Them?

5 Dividend Stocks Poised to Profit From the AI Efficiency Boom

JNJ

Motley Fool

7 days ago

5 Dividend Stocks Poised to Profit From the AI Efficiency Boom

J&J introduces disposable contact lens for astigmatism and presbyopia

JNJ

Medical Device Network

7 days ago

J&J introduces disposable contact lens for astigmatism and presbyopia

Compass’s Psychedelic Drug to Treat Depression Meets Goal in Trial

JNJ

Bloomberg

8 days ago

Compass’s Psychedelic Drug to Treat Depression Meets Goal in Trial

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

JNJ

Zacks

8 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?

JNJ

Zacks

8 days ago

J&J Adds More Than $15B in Six Months: How to Play JNJ Stock?

J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications

JNJ

Zacks

8 days ago

J&J's Drugs Get CHMP Recommendations for Blood Cancer Indications

JNJ

MT Newswires

8 days ago

Johnson & Johnson's Imaavy Shows 'Significant Improvement' Over Other Treatments for Autoimmune Disorder

Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM

JNJ

PR Newswire

8 days ago

Johnson & Johnson Launches First and Only Daily Disposable Multifocal Toric Contact Lens - ACUVUE OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM

IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC)

JNJ

PR Newswire

8 days ago

IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC)

JNJ

Zacks

8 days ago

Zacks Investment Ideas feature highlights: Jabil, Apple, Amazon, Johnson & Johnson and Ericsson

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'

JNJ

Benzinga

9 days ago

Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'

JNJ’s Consistent Payout Makes It a Top Pick for Down Markets

JNJ

Insider Monkey

10 days ago

JNJ’s Consistent Payout Makes It a Top Pick for Down Markets

IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant

JNJ

GlobeNewswire

11 days ago

IMBRUVICA® (ibrutinib) receives positive CHMP opinion for the treatment of patients with previously untreated mantle cell lymphoma (MCL) who would be eligible for autologous stem cell transplant

Johnson & Johnson (NYSE:JNJ) Faces US$8 Million Verdict Over Talcum Powder Cancer Case

JNJ

Simply Wall St.

11 days ago

Johnson & Johnson (NYSE:JNJ) Faces US$8 Million Verdict Over Talcum Powder Cancer Case

$J&J MedTech introduces new plates for VOLT fracture management platform$

JNJ

Medical Device Network

11 days ago

J&J MedTech introduces new plates for VOLT fracture management platform

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

JNJ

Zacks

12 days ago

Johnson & Johnson (JNJ) is Attracting Investor Attention: Here is What You Should Know

Trump administration weighs crackdown on pharma ads, Bloomberg says

JNJ

TipRanks

13 days ago

Trump administration weighs crackdown on pharma ads, Bloomberg says

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

JNJ

Zacks

13 days ago

Should You Invest in the Invesco Pharmaceuticals ETF (PJP)?

Johnson & Johnson rolls out TECNIS Odyssey IOL in selected regions

JNJ

Medical Device Network

13 days ago

Johnson & Johnson rolls out TECNIS Odyssey IOL in selected regions

JNJ

Motley Fool

13 days ago

2 Dividend Stocks to Buy and Never Sell

Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)

JNJ

Motley Fool

13 days ago

Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)

Trump's big beautiful bill: What the pharma industry is watching

JNJ

Yahoo Finance Video

13 days ago

Trump's big beautiful bill: What the pharma industry is watching

Johnson & Johnson’s Q1 Earnings Call: Our Top 5 Analyst Questions

JNJ

StockStory

13 days ago

Johnson & Johnson’s Q1 Earnings Call: Our Top 5 Analyst Questions

JNJ

MT Newswires

14 days ago

Market Chatter: Trump Administration to Consider Pharma Advertising Crackdown

ISRG's Minimally Invasive Ecosystem Powers Surgical Precision

JNJ

Zacks

14 days ago

ISRG's Minimally Invasive Ecosystem Powers Surgical Precision

Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know

JNJ

Zacks

14 days ago

Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know

Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?

JNJ

Zacks

15 days ago

Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE?

J&J reports results from antibody combo trial for MM patients

JNJ

Clinical Trials Arena

15 days ago

J&J reports results from antibody combo trial for MM patients

JNJ

MT Newswires

15 days ago

Johnson & Johnson Says Drug Combo Study Shows 'Deep, Durable' Responses Multiple Myeloma Patients With Extramedullary Disease

Pharma manufacturing 'boom' faces high costs, potential delays

JNJ

Yahoo Finance

16 days ago

Pharma manufacturing 'boom' faces high costs, potential delays

Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

JNJ

PR Newswire

16 days ago

Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease

Johnson & Johnson (NYSE:JNJ) Unveils Promising CAR T-Cell Therapy for B-Cell Lymphoma

JNJ

Simply Wall St.

16 days ago

Johnson & Johnson (NYSE:JNJ) Unveils Promising CAR T-Cell Therapy for B-Cell Lymphoma

UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times

JNJ

Insider Monkey

17 days ago

UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times

Healthcare Sector Taps AI Boom via Intuitive Surgical Stock (ISRG)

JNJ

TipRanks

17 days ago

Healthcare Sector Taps AI Boom via Intuitive Surgical Stock (ISRG)

JNJ

MT Newswires

17 days ago

Sector Update: Health Care Stocks Softer Friday Afternoon

Senators to propose ban on drug ads to consumers, WSJ reports

JNJ

TipRanks

17 days ago

Senators to propose ban on drug ads to consumers, WSJ reports

JNJ

MT Newswires

18 days ago

Johnson & Johnson Says Therapy Shows 'Encouraging' First Trial Results in Large B-cell Lymphoma

JPMorgan biotech/pharma analysts hold analyst/industry conference call

JNJ

TipRanks

18 days ago

JPMorgan biotech/pharma analysts hold analyst/industry conference call

Johnson & Johnson announces new Phase 1b data on bleximenib

JNJ

TipRanks

18 days ago

Johnson & Johnson announces new Phase 1b data on bleximenib

Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma

JNJ

PR Newswire

18 days ago

Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma

BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth?

JNJ

Zacks

18 days ago

BSX Q1 Endoscopy Sales Rise 6%: What's Behind the Growth?

Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead?

JNJ

Motley Fool

18 days ago

Should You Forget Johnson & Johnson and Buy This Magnificent High-Yield Stock Instead?

JNJ

MT Newswires

19 days ago

Johnson & Johnson Says Phase 1b Trial Shows Promise for Bleximenib Combo in AML Treatment

New results for Johnson & Johnson's bleximenib demonstrate promising antileukemic activity in combination with venetoclax and azacitidine for acute myeloid leukemia

JNJ

PR Newswire

19 days ago

New results for Johnson & Johnson's bleximenib demonstrate promising antileukemic activity in combination with venetoclax and azacitidine for acute myeloid leukemia

J&J’s Tremfya reduces active psoriatic arthritis symptoms in Phase IIIb trial

JNJ

Clinical Trials Arena

19 days ago

J&J’s Tremfya reduces active psoriatic arthritis symptoms in Phase IIIb trial

Judge Orders J&J Subsidiary to Pay $442 Million in Antitrust Lawsuit

JNJ

Insider Monkey

19 days ago

Judge Orders J&J Subsidiary to Pay $442 Million in Antitrust Lawsuit

Daniel Pinto Joins Johnson & Johnson (NYSE:JNJ) Board Bringing Extensive Financial Expertise

JNJ

Simply Wall St.

19 days ago

Daniel Pinto Joins Johnson & Johnson (NYSE:JNJ) Board Bringing Extensive Financial Expertise

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

JNJ

TipRanks

20 days ago

Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel

Why Johnson & Johnson (JNJ) is a Top Momentum Stock for the Long-Term

JNJ

Zacks

20 days ago

Why Johnson & Johnson (JNJ) is a Top Momentum Stock for the Long-Term

JNJ vs. MRK: Which Healthcare Titan Offers Better Growth Prospects?

JNJ

Zacks

20 days ago

JNJ vs. MRK: Which Healthcare Titan Offers Better Growth Prospects?

JNJ

Zacks

20 days ago

The Zacks Analyst Blog Highlights Johnson & Johnson, T-Mobile, The Boeing and Franklin Financial Services

JNJ

MT Newswires

20 days ago

Johnson & Johnson Says Tremfya Reduces Psoriatic Arthritis Signs, Symptoms in Phase 3b Trial

New data show TREMFYA® (guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis

JNJ

PR Newswire

20 days ago

New data show TREMFYA® (guselkumab) is the only IL-23 inhibitor proven to significantly inhibit progression of joint structural damage in active psoriatic arthritis

Why defensive stocks could be your best bet in a wild market

JNJ

Yahoo Finance Video

20 days ago

Why defensive stocks could be your best bet in a wild market

JNJ

Medical Device Network

20 days ago

Johnson & Johnson MedTech introduces surgical stapler for tissue complexity

Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors

JNJ

Business Wire

20 days ago

Johnson & Johnson Elects Daniel Pinto, President, JPMorganChase to its Board of Directors

Top Analyst Reports for Johnson & Johnson, T-Mobile US & Boeing

JNJ

Zacks

20 days ago

Top Analyst Reports for Johnson & Johnson, T-Mobile US & Boeing

RFK Jr. removes CDC vaccine panel members: What to know

JNJ

Yahoo Finance Video

21 days ago

RFK Jr. removes CDC vaccine panel members: What to know

Have Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE?

JNJ

Zacks

21 days ago

Have Skyrizi and Rinvoq Successfully Saved AbbVie From Humira LoE?

Judge rules J&J unit must pay $442M in antitrust case

JNJ

MedTech Dive

22 days ago

Judge rules J&J unit must pay $442M in antitrust case

Corporate cash levels are starting to fall

JNJ

Bloomberg

23 days ago

Corporate cash levels are starting to fall

Patents and economies of scale support Pfizer's wide moat

JNJ

GuruFocus.com

24 days ago

Patents and economies of scale support Pfizer's wide moat

Challenges pharma companies face in push into US manufacturing

JNJ

Yahoo Finance Video

24 days ago

Challenges pharma companies face in push into US manufacturing

JNJ

MT Newswires

25 days ago

Sector Update: Health Care Stocks Edge Higher Thursday Afternoon

JNJ

MT Newswires

25 days ago

Sector Update: Health Care

JNJ

MT Newswires

25 days ago

Johnson & Johnson Has Strong Drug Pipeline to Treat Cancer, Other Diseases, RBC Says

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

JNJ

Zacks

a month ago

Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It

JNJ's Combo Therapy Shows Strong Phase III Efficacy in Prostate Cancer

JNJ

Zacks

a month ago

JNJ's Combo Therapy Shows Strong Phase III Efficacy in Prostate Cancer

J&J may take a softer tariff hit after US-China pause, CFO says

JNJ

MedTech Dive

a month ago

J&J may take a softer tariff hit after US-China pause, CFO says

Johnson & Johnson MedTech introduces automated system for surgical efficiency

JNJ

Medical Device Network

a month ago

Johnson & Johnson MedTech introduces automated system for surgical efficiency

Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts

JNJ

Zacks

a month ago

Johnson & Johnson (JNJ) Stock Dips While Market Gains: Key Facts

ASCO25: J&J’s trispecific antibody shows 100% response in Phase I multiple myeloma study

JNJ

Pharmaceutical Technology

a month ago

ASCO25: J&J’s trispecific antibody shows 100% response in Phase I multiple myeloma study

JNJ

MT Newswires

a month ago

Johnson & Johnson's Darzalex Faspro Regimen Improves Progression-Free Survival in Two Phase 3 Myeloma Trials

$Single infusion of CARVYKTI® (ciltacabtagene autoleucel) delivered lasting treatment-free remissions for at least five years in patients with relapsed or refractory multiple myeloma$

JNJ

PR Newswire

a month ago

Single infusion of CARVYKTI® (ciltacabtagene autoleucel) delivered lasting treatment-free remissions for at least five years in patients with relapsed or refractory multiple myeloma

Early results from Johnson & Johnson's trispecific antibody show promising response in heavily pretreated multiple myeloma patients

JNJ

PR Newswire

a month ago

Early results from Johnson & Johnson's trispecific antibody show promising response in heavily pretreated multiple myeloma patients

JNJ

MT Newswires

a month ago

Johnson & Johnson Says Akeega Has Potential to Slow Castration-Sensitive Prostate Cancer Growth

Johnson & Johnson leads with first PARP inhibitor combo to improve efficacy in patients with HRR-altered mCSPC

JNJ

PR Newswire

a month ago

Johnson & Johnson leads with first PARP inhibitor combo to improve efficacy in patients with HRR-altered mCSPC

How leading oncology drugmakers set the stage for future advances

JNJ

Pharma Voice

a month ago

How leading oncology drugmakers set the stage for future advances

Johnson & Johnson (NYSE:JNJ) Unveils Promising Prostate Cancer Data With Pasritamig

JNJ

Simply Wall St.

a month ago

Johnson & Johnson (NYSE:JNJ) Unveils Promising Prostate Cancer Data With Pasritamig

ASCO25: Johnson & Johnson reports data from Phase I trial of prostate cancer drug

JNJ

Clinical Trials Arena

a month ago

ASCO25: Johnson & Johnson reports data from Phase I trial of prostate cancer drug

COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?

JNJ

Zacks

a month ago

COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?

HistoSonics’ histotripsy system receives early market access authorisation in UK

JNJ

Medical Device Network

a month ago

HistoSonics’ histotripsy system receives early market access authorisation in UK

3 Elite High-Yield Dividend Stocks Down 8% to 27% That Have Hiked Their Payouts for More than 50 Years in a Row

JNJ

Motley Fool

a month ago

3 Elite High-Yield Dividend Stocks Down 8% to 27% That Have Hiked Their Payouts for More than 50 Years in a Row

Johnson & Johnson (JNJ) Stock Moves -0.54%: What You Should Know

JNJ

Zacks

a month ago

Johnson & Johnson (JNJ) Stock Moves -0.54%: What You Should Know

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

JNJ

Business Wire

a month ago

Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results

Boston Scientific ends TAVR sales; J&J shares Monarch robot data

JNJ

MedTech Dive

a month ago

Boston Scientific ends TAVR sales; J&J shares Monarch robot data

1 Top Dividend Stock to Buy for a Lifetime of Passive Income

JNJ

Motley Fool

a month ago

1 Top Dividend Stock to Buy for a Lifetime of Passive Income

JNJ

Insider Monkey

a month ago

US FDA Votes in Favor of Benefit-Risk Profile of Johnson & Johnson’s DARZALEX FASPRO

Generating Passive Income: 3 Top Dow Dividend Stocks to Buy for 2025 and Beyond

JNJ

Motley Fool

a month ago

Generating Passive Income: 3 Top Dow Dividend Stocks to Buy for 2025 and Beyond

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

JNJ

Zacks

a month ago

Johnson & Johnson (JNJ) Declines More Than Market: Some Information for Investors

JNJ Down 6% in 3 Months: How to Play the Stock Amid Various Challenges

JNJ

Zacks

a month ago

Latest Johnson & Johnson (JNJ) News on July 1, 2025

Share on Social Networks: